Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS) (SDALS-001)
This study has been completed.
Sponsor:
Nazem Atassi
Collaborators:
ALS Therapy Alliance
State University of New York - Upstate Medical University
Information provided by (Responsible Party):
Nazem Atassi, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01257581
First received: December 8, 2010
Last updated: March 12, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2013 |
| Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |